Cyberounds Logo
August 11, 2020 | LOGIN | REGISTER | HELP | 

email a friend print Bookmark and Share
A Rational Approach to the Diagnosis and Treatment of Narrow QRS Complex Tachycardias
CME credit is no longer available for this conference.
Greg Pepper, M.D., and Ann Dougherty, M.D.

Dr. Dougherty is Associate Professor of Medicine, The University of Texas Medical School at Houston and Dr. Greg Pepper is an Electrophysiology fellow at UT.

Drs. Pepper and Dougherty report no commercial conflict of interest.

This activity is made possible by an unrestricted educational grant from Pfizer.

Release Date: 10/02/2001
Termination Date: 10/02/2004

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Describe the mechanisms of the most common narrow QRS complex tachycardias
  • Discuss the distinguishing electrocardiographic features of the narrow QRS complex tachycardias
  • Discuss current treatments of the narrow QRS complex tachycardias.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity